Nishi, Kentaro
Ogura, Masao
Ishiwa, Sho
Kanamori, Toru
Okutsu, Mika
Yokota, Shunsuke
Nada, Taishi
Sato, Mai
Kamei, Koichi
Ishikura, Kenji
Ito, Shuichi http://orcid.org/0000-0002-5242-8987
Article History
Received: 2 September 2021
Revised: 19 October 2021
Accepted: 24 October 2021
First Online: 26 January 2022
Declarations
:
: This study (No. 1868) was approved by the Ethics Committee of the National Center for Child Health and Development.
: Informed consent for participating in this study was not required in accordance with the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects of the Ministry of Health, Labor, and Welfare.
: Consent for publication was waived in accordance with the guidelines.
: Koichi Kamei has received research funding from the Terumo Foundation for Life Sciences and Arts, Public Foundation of Vaccination Research Center, and Taiju Life Social Welfare Foundation and donations from Ono Pharmaceutical Co., Ltd. Kenji Ishikura has received lecture fees from Asahi Kasei Pharma, Chugai Pharmaceutical Co., Ltd, Zenyaku Kogyo Co., Ltd, and Novartis Pharma K.K. and grants from Asahi Kasei Pharma, Chugai Pharmaceutical Co., Ltd., Novartis Pharma, and Zenyaku Kogyo Co., Ltd. Shuichi Ito has received honoraria and research funding from Asahi Kasei Pharma, Chugai Pharmaceutical Co., Ltd, Zenyaku Kogyo Co., Ltd, and Astellas PHARMA Co., Ltd. Other authors have no potential conflicts of interest to disclose.